China
GSK to make ‘fundamental changes’
February 6, 2014Sales and Marketing China, GSK, Tafinlar, Witty, q4, results
GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
Actavis: China is ‘too risky’
January 17, 2014Sales and Marketing Actavis, China, bribery, generics, risky
The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …
China ban for corrupt pharma firms
January 2, 2014Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly
Prime minister backs GSK in corruption row
December 4, 2013Medical Communications, Sales and Marketing China, GSK, bribery, david cameron
Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …
Witty goes to China
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …
GSK using ‘sledgehammer’ tactics on agencies
November 29, 2013Sales and Marketing Cameron, China, GSK, horlicks, sky
GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …
GSK ‘may not face corporate charges’
November 5, 2013Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …
Corruption probe hits GSK
October 24, 2013Sales and Marketing China, GSK, Q3, corruption
The fallout from corruption investigations in China has hit GlaxoSmithKline, which announced third quarter sales in the country were down …
Travel ban ambiguity for GSK ‘s former China boss
October 17, 2013Sales and Marketing China, GSK, bribery, reilly
GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …
Lilly staff ‘divulged secrets’
October 10, 2013Medical Communications, Sales and Marketing China, bribery, lilly
Two former staff from Eli Lilly & Company have been accused in a US court of passing on industrial secrets …
Boehringer cuts ribbon on €70m addition to Shanghai plant
September 27, 2013Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai
Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …
Amgen to open Chinese R&D centre
September 26, 2013Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang
Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …
Novartis launches China investigation
September 18, 2013Medical Communications, Sales and Marketing Alcon, China, Novartis, corrpution
Bayer faces China investigation
September 16, 2013Medical Communications, Sales and Marketing Bayer, China, corruption
